שילוב של רגורפניב ו pd-1/pd-l1(2) לטיפול בסרטן

• 收藏
• 分享

专利权人:

BAYER AKTIENGESELLSCHAFT

发明人:

申请号：

IL27094819

公开号：

IL270948D0

申请日:

2019.11.26

申请国别(地区):

IL

年份:

2020

代理人:

摘要：

The present invention relates to pharmaceutical compositions and combinations comprising regorafenib or its hydrate, solvate, metabolite or pharmaceutically acceptable salt or a polymorph thereof and a PD-1/PD-L1(2) inhibitor for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/